Migdal Insurance & Financial Holdings’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,114
Closed -$435K 592
2021
Q1
$435K Buy
1,114
+691
+163% +$340K ﹤0.01% 333
2020
Q4
$237K Buy
+423
New +$268K ﹤0.01% 299

Other funds holding BLUE

Migdal Insurance & Financial Holdings's BLUE Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 1,114 shares — an estimated $435K sold.

Migdal Insurance & Financial Holdings first reported a position in BLUE in Q4 2020 and held it in 2 quarters. The position peaked at $435K in Q1 2021. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 1,114 bluebird bio shares in Q2 2021, an estimated $435K.
  • Migdal Insurance & Financial Holdings first reported a position in bluebird bio in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's bluebird bio position peaked at $435K in Q1 2021.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.